239 related articles for article (PubMed ID: 10890355)
21. Cell-free HIV-1Zr6 vif mutants are defective in binding to peripheral blood mononuclear cells and in internalization.
Nagashunmugam T; Friedman HM
DNA Cell Biol; 1996 May; 15(5):353-61. PubMed ID: 8924209
[TBL] [Abstract][Full Text] [Related]
22. Role of Vif in human immunodeficiency virus type 1 reverse transcription.
Goncalves J; Korin Y; Zack J; Gabuzda D
J Virol; 1996 Dec; 70(12):8701-9. PubMed ID: 8970997
[TBL] [Abstract][Full Text] [Related]
23. Analysis of vif-defective human immunodeficiency virus type 1 (HIV-1) virions synthesized in 'non-permissive' T lymphoid cells stably infected with selectable HIV-1.
Ochsenbauer C; Wilk T; Bosch V
J Gen Virol; 1997 Mar; 78 ( Pt 3)():627-35. PubMed ID: 9049414
[TBL] [Abstract][Full Text] [Related]
24. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
25. Productive replication of Vif-chimeric HIV-1 in feline cells.
Stern MA; Hu C; Saenz DT; Fadel HJ; Sims O; Peretz M; Poeschla EM
J Virol; 2010 Jul; 84(14):7378-95. PubMed ID: 20463079
[TBL] [Abstract][Full Text] [Related]
26. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
[TBL] [Abstract][Full Text] [Related]
27. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes.
Simm M; Shahabuddin M; Chao W; Allan JS; Volsky DJ
J Virol; 1995 Jul; 69(7):4582-6. PubMed ID: 7769728
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions.
Gaddis NC; Chertova E; Sheehy AM; Henderson LE; Malim MH
J Virol; 2003 May; 77(10):5810-20. PubMed ID: 12719574
[TBL] [Abstract][Full Text] [Related]
29. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity.
Ma XY; Sova P; Chao W; Volsky DJ
J Virol; 1994 Mar; 68(3):1714-20. PubMed ID: 8107232
[TBL] [Abstract][Full Text] [Related]
30. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
[TBL] [Abstract][Full Text] [Related]
31. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
Dornadula G; Yang S; Pomerantz RJ; Zhang H
J Virol; 2000 Mar; 74(6):2594-602. PubMed ID: 10684273
[TBL] [Abstract][Full Text] [Related]
32. Follicular dendritic cells and human immunodeficiency virus type 1 transcription in CD4+ T cells.
Thacker TC; Zhou X; Estes JD; Jiang Y; Keele BF; Elton TS; Burton GF
J Virol; 2009 Jan; 83(1):150-8. PubMed ID: 18971284
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the single cycle replication of HIV-1 expressing Gaussia luciferase in human PBMCs, macrophages, and in CD4(+) T cell-grafted nude mouse.
Ao Z; Huang J; Tan X; Wang X; Tian T; Zhang X; Ouyang Q; Yao X
J Virol Methods; 2016 Feb; 228():95-102. PubMed ID: 26640121
[TBL] [Abstract][Full Text] [Related]
34. Association of human immunodeficiency virus type 1 Vif with RNA and its role in reverse transcription.
Dettenhofer M; Cen S; Carlson BA; Kleiman L; Yu XF
J Virol; 2000 Oct; 74(19):8938-45. PubMed ID: 10982337
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
[TBL] [Abstract][Full Text] [Related]
36. Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene.
Ometto L; Zanchetta M; Cabrelle A; Esposito G; Mainardi M; Chieco-Bianchi L; De Rossi A
AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1441-52. PubMed ID: 10555107
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
[TBL] [Abstract][Full Text] [Related]
38. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein.
Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E
J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465
[TBL] [Abstract][Full Text] [Related]
39. Cellular and viral specificities of human immunodeficiency virus type 1 vif protein.
Madani N; Kabat D
J Virol; 2000 Jul; 74(13):5982-7. PubMed ID: 10846079
[TBL] [Abstract][Full Text] [Related]
40. Efficiency of viral DNA synthesis during infection of permissive and nonpermissive cells with vif-negative human immunodeficiency virus type 1.
Sova P; Volsky DJ
J Virol; 1993 Oct; 67(10):6322-6. PubMed ID: 8371360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
